2026

Elise Dalmas: Neckar Hospital for Sick Children - France
TGFβ signaling imprints islet-resident macrophage identity: impact on ß cell pathophysiology?

Marta Perez Frances: University of Geneva - Switzerland
Decoding Epigenetic and Transcriptional Barriers to Human ß-Cell Proliferation for Diabetes Therapy

Francesca Spagnoli: King's College London - UK
Characterising immune-endocrine interactions in human foetal pancreas

Nicolas Venteclef: INSERM - France
Itaconate Defines a Metabolic Checkpoint in Resident Adipose Macrophages in Diabetes

2025

Amandine Gautier-Stein: University of Lyon - France 
The vesicular pathway of glucose production is an innovative strategy for preventing and treating type 2 diabetes

Doris Kaltenecker: Institute for Diabetes and Cancer, Helmholtz Munich - Germany 
Spatial characterization into obesity-driven changes of the trigeminal ganglion

Hannele Yki-Järvinen: Helsinki University Hospital and Minerva Foundation Institute for Medical research - Finland 
Modulation of glucose-alanine cycling in humans as a novel target to treat type 2 diabetes

Inga Prokopenko: University of Surrey - UK 
Precision medicine for personalized Incretin mimetics therapy 

José Javier Fuster-Ortuño: National Center for Cardiovascular Research, (CNIC) - Madrid, Spain 
Dissecting the link between clonal haematopoiesis and type 2 diabetes

Maike Sander: Max Delbrück Center for Molecular Medicine - Berlin, Germany 
Enhancing Stem-Cell-Derived Beta Cell Maturation: Integrating Reporters and CRISPR Screens

2024

Brice Emanuelli: University of Copenhagen - Denmark
Elucidation of a novel ketone-fatty acid cycling in the function of brown adipose tissue

Federica Benvenuti: International Centre for Genetic Engineering and Biotechnology (ICGEB) - Trieste, Italy
Does hyperglycaemia suppress tumor immune surveillance by dendritic cells?

Isabella Artner: Lund University - Malmö, Sweden
Characterizing the function of novel islet transcription factors AUTS2 and ETV1 in human pancreatic islet development and function

Maria Lindahl: University of Helsinki - Finland
Novel METTL3/14 methyltransferase activators for protecting pancreatic beta cells in diabetes mellitus

Nadav Sharon: Technion, Israel Institute of Technology - Haifa, Israel
Uncovering the Heterogeneous Potential of Pancreatic Beta Cell Proliferation

2023

Alastair Kerr: Karolinska Institute - Huddinge, Sweden
A missing link (RNA) in fat breakdown regulation

Fredrik Bäckhed: University of Gothenburg - Sweden
Gut microbial regulation of colonic GLP-1 production and effects on gut physiology

Jurga Laurencikiene: Karolinska Institute - Huddinge, Sweden
Type 2 diabetes and adipose tissue morphology: dual role and sex-specificity of the immune component

Luis Rodrigo Cataldo: Lund University - Malmö, Sweden
EPDR1 – a novel human batokine regulating beta cell function and glucose homeostasis

Zachary Gerhart-Hines: University of Copenhagen - Denmark
Nocturnal thermogenesis as a driver of metabolic health and defense against weight gain in humans

2022

Filip Knop: University of Copenhagen - Denmark
Separate and combined extrapancreatic effects of the incretin hormones

Gil Leibowitz: Hadassah-Hebrew University Medical Center - Jerusalem, Israel
Fructose is central in diabetic kidney disease and mediates the protective effects of SGLT2 inhibitors

Peter van Endert: INSERM U1151 - Paris, France
Tolerogenic nanoparticles inducing regulatory B and T lymphocytes for therapy of autoimmune diabetes

Sonia Fernandez Veledo: Pere Virgili Health Research Institute - Tarragona, Spain
NEUROinflammatory role of the succinate/SUCNR1 axis in obesity-related DIAbetes (NEURO_DIA)

Vito Lampasona: Vita-Salute San Raffaele University - Milan, Italy
Insulin granules proteins: novel autoimmune targets and biomarkers in type 1 diabetes